GLP-1 Market
LLY $1410.99 ▼ -0.5% NVO $40.45 ▲ +1.1% PFE $30.67 ▲ +0.5% VKTX $26.83 ▼ -1.6% KLRA $12.15 ▼ -5.5% GPCR $20.47 ▼ -6.4% RHHBY $60.68 ▼ -1.0%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Intralipid, 20% Emulsion

Company
University of North Carolina, Chapel Hill
Mechanism
Mechanism not yet reported
Route
Injectable
Recruiting trials
None currently listed

Efficacy results: Not yet reported

No recruiting studies currently listed

See all studies for this drug

Data source: ClinicalTrials.gov · trial data as of Nov 3, 2026

Trial details
  • Completed NCT NCT00672854

    Study Comparing a Soybean Oil-Based With an Olive Oil-Based Lipid Emulsion in ICU Patients Requiring TPN

    Not yet reported, Not yet reported Emory University 100 participants Est. completion 2010-12 2 sites
    Other conditions: Parenteral Nutrition
    View official trial listing →
  • Completed NCT NCT03387579

    Comparison of Smoflipid to Soy-based Lipid Reduction for Cholestasis Prevention in Surgical Neonates

    Not yet reported Indiana University 24 participants Est. completion 2024-03-19 1 site Stand-alone
    Other conditions: Cholestasis of Parenteral Nutrition
    View official trial listing →
  • Completed NCT NCT03479671

    Low Dose Fat-Induced Insulin Resistance

    Not yet reported University of Pennsylvania 9 participants Est. completion 2024-11-19 1 site Stand-alone
    Type 2 diabetes Other conditions: Insulin Resistance, Insulin Sensitivity
    View official trial listing →
  • Completed NCT NCT03857646

    The Effect of Lipid Emulsions on Free Fatty Acids and Free Bilirubin in Premature Newborns

    Not yet reported The University of Texas Health Science Center, Houston 66 participants Est. completion 2020-06-11 1 site
    Other conditions: Prematurity
    View official trial listing →
  • Withdrawn NCT NCT04274803

    Dose Intralipid Infusion Reduces Pregnancy Complications Caused by Antiphospholipid Antibody Syndrome?

    Not yet reported Tanta University Est. completion 2021-05-31 1 site Stand-alone
    Other conditions: Antiphospholipid Syndrome in Pregnancy
    View official trial listing →
  • Completed NCT NCT04328337

    Investigating Whether Acute Elevation of Fatty Acid Levels Alters Cerebral Glucose Transport and Metabolism

    Not yet reported, Not yet reported University of North Carolina, Chapel Hill 40 participants Est. completion 2026-06-01 2 sites Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Withdrawn NCT NCT04393103

    Role of Intralipid in Management of Organophosphorus Poisoning

    Not yet reported, Not yet reported Amani Hassan Abdel-Wahab Est. completion 2025-01-01 Stand-alone
    Other conditions: Organophosphorus Poisoning
    View official trial listing →
  • Completed NCT NCT04558190

    Mitochondrial Dysfunction and Insulin Resistance in Skeletal Muscle

    Not yet reported University of Copenhagen 10 participants Est. completion 2021-11-01 1 site Stand-alone
    Other conditions: Insulin Resistance
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Intralipid, 20% Emulsion, Intralipid, 20% Intravenous Emulsion

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.